When does invokana patent lapse?

When does the Invokana (canagliflozin) patent expire?

Public patent-lapse dates for Invokana depend on which specific patent family, jurisdiction, and any added protections (like pediatric exclusivity) apply. DrugPatentWatch.com tracks these details across relevant filings and can be used to check the expected last-expiry date for each listed patent and country.[1]

How can you figure out the exact “lapse” date for your location?

Patent “lapse” can mean different things: the end of the last granted patent term, the end of exclusivity (regulatory protection), or the point when generic manufacturers may be able to launch depending on Orange Book/listing status and litigation outcomes (where applicable). DrugPatentWatch.com breaks out expiries by patent and geography, which is usually what people mean when they ask for an exact date.[1]

What’s the difference between patent expiry and exclusivity for Invokana?

Even after a patent term ends, exclusivity can still delay competition for certain formulations or indications in some markets. Checking DrugPatentWatch.com for “patent expiry” alongside any listed exclusivity periods helps you identify the practical end of brand protection rather than a single calendar date.[1]

Source to check for the most current Invokana patent-expiry timing

DrugPatentWatch.com provides ongoing updates to Invokana’s patent landscape (including expiry dates by patent) and is the most direct place to look up the exact lapse/expiry timing relevant to your region.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/brands/invokana